YAG Laser Vitreolysis for Vitreous Floaters
NCT: NCT06915922 · COMPLETED
Brief Summary
The purpose of this study is to measure how the quality of life, the structure of eye, and vision change after treatment for the opacities in the gel (vitreous) that fills the center of eye which cause vision disturbances commonly called "floaters". In this study the vitreous floaters are treated using a Neodymium-doped yttrium-aluminum-garnet (Nd:YAG) laser. The FDA has approved the use of this laser to treat membranes in the eye.
Frequently Asked Questions
What is YAG Laser Vitreolysis for Vitreous Floaters?
YAG Laser Vitreolysis for Vitreous Floaters is a clinical trial registered under NCT06915922. Current status: COMPLETED.
What is the status of NCT06915922?
The current status of NCT06915922 (YAG Laser Vitreolysis for Vitreous Floaters) is: COMPLETED.
When did YAG Laser Vitreolysis for Vitreous Floaters start?
YAG Laser Vitreolysis for Vitreous Floaters started on 2023-10-17.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.